A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Summary

The study compares two semaglutide medicines and looks at how well they control blood sugar levels, in participants with type 2 diabetes (T2D). Participants will either get the currently available semaglutide or the semaglutide which is produced through a new manufacturing process. Participants need to take one injection of semaglutide once a week, on the same day of every week. Participants will have a total of 11 clinic visits and the study will last for about 35 weeks (approximately 8 months).

Timeline

Start

2022-08-03

Primary completion

2023-08-09

Completion

2023-09-18

Drugs

Indications